2.35 million people in India are HIV-positive. About 1.5 million people are on antiretroviral therapy, far lower than the World Health Organization’s “90-90-90 target” – under which 90% of people with HIV are diagnosed, 90% are on ARV treatment, and 90% are no longer infectious. In 2019, an estimated 58,900 Aids-related deaths were reported in the country.
India says it aims to end the HIV epidemic by 2030.
Up to 500,000 people have not been able to get hold of free ARVs from government health centres and hospitals over the past five months, they say, as the country experiences stock shortages of key drugs.
ARVs that are available in privately run pharmacies and shops can be prohibitively expensive. Some people have been given alternative drugs, but others have stopped taking any medication.
“Does the government even realise that at least 500,000, or one-third of the patients, are affected by this? Some adults are being given 11 doses of paediatric medicine to compensate,” said Loon Gangte, president of the Delhi Network of Positive People (DNP+), an NGO that works to improve the treatment and facilities for people living with HIV and Aids. “We only demand an uninterrupted monthly supply. This treatment is our right.”
Kedar Nath, a 30-year-old street vendor taking part in the protest, said he has not taken his ARVs on several occasions over the past two months. He cannot afford the £50 a month it would cost to buy the drugs on the open market.
“I have been taking these drugs for the last 13 years. They have helped me continue with my life despite the virus in my body. But the recent shortage has turned my life upside down since I can neither find the strength to work, nor have any savings to live off,” he said.
India’s HIV patients say shortages leaving hundreds of thousands without drugs | Global development | The Guardian
Post a Comment